HomeGERN • NASDAQ
add
Geron Corp
Previous close
$4.99
Day range
$4.72 - $4.94
Year range
$1.64 - $5.34
Market cap
2.82B USD
Avg Volume
14.67M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 304.00K | 1,347.62% |
Operating expense | 27.06M | 109.90% |
Net income | -55.39M | -45.30% |
Net profit margin | -18.22K | 89.96% |
Earnings per share | -0.09 | -28.57% |
EBITDA | -56.02M | -40.08% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 443.05M | 16.36% |
Total assets | 482.07M | 13.46% |
Total liabilities | 137.21M | 38.84% |
Total equity | 344.87M | — |
Shares outstanding | 593.13M | — |
Price to book | 8.60 | — |
Return on assets | -32.03% | — |
Return on capital | -36.68% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -55.39M | -45.30% |
Cash from operations | -62.25M | -34.27% |
Cash from investing | 34.21M | 119.14% |
Cash from financing | 147.80M | -47.41% |
Net change in cash | 119.74M | 114.08% |
Free cash flow | -42.16M | -25.14% |
About
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase. Wikipedia
Founded
1990
Headquarters
Website
Employees
141